CrystalGenomics

CrystalGenomics is a leading structure-based chemoproteomics drug discovery and development company headquartered in Seoul, South Korea, with a U.S. subsidiary, CG Pharmaceuticals, Inc., located in Emeryville, California, responsible for multinational clinical management. CrystalGenomics has established multiple drug discovery collaborations with leading pharmaceutical companies and VC groups, including AstraZeneca and Daiichi-Sankyo. The company is publicly traded on the KOSDAQ exchange (Seoul, South Korea).